Form D · Pharmaceuticals
Scienture Inc.
Hauppauge, NY · CIK 0001831852
Offering snapshot reported Dec 14, 2020 · SEC filing
- Reported sold
- $6M Indefinite offering
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 20, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 14, 2020 | Initial | $6,000,000 | No comparison | 24 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-383084
Source: Form D, filed Dec 14, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shankar Hariharan | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
150 Motor Parkway, Suite 401
Hauppauge, NY, 11788
Hauppauge, NY, 11788